Saturday, April 22, 2006

THE CERTIFIED METHADONE ADVOCATE (CMA) TRAINING COURSE
Additional Fees Apply – See Below for Registration Information

TIME: 8:00 AM – 9:00 AM (Pre-Registration)
           9:00AM – 5:00 PM (Training Course)

Frederick W. Christie, MA
AFIRM
Long Island, NY

Rebecca Brooks, CMA
NAMA/LHRC
Ontario, Canada

Sharon Dembinski, MS
NAMA
Webster, MA

Ray Caesar
OKDMHSAS/SMA
Oklahoma City, OK

Herman Joseph, PhD
NAMA
New York, NY

Joycelyn Woods, MA
NAMA/Faces & Voices of Recovery
New York, NY

Thomas Kresina, PhD
NIDA/CSAT
Rockville, MD

J. Thomas Payte, MD
Colonial Management Group
Orlando, FL

Legal Action Center
New York, NY

It is the view of the National Alliance of Methadone Advocates (NAMA) that everyone who supports the use of methadone treatment is a potential methadone advocate. We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates (CMA) so that all energies directed toward the advancement of methadone treatment produce positive results.

This course fulfills the training requirement for Certification as a Methadone Advocate. This course involves 8 hours of rigorous training.

With these goals in mind the course presentation is constituted as follows:

• Addiction and Methadone – scientifically accurate yet in language understandable to the non-clinician.
  
• Regulations and Accreditation – explained by experts from CSAT who understand the systemic complexity of ODT. Advocacy through collaboration specifically State Methadone Authority contact.
  
• Methadone Mythology – exposing of the myths surrounding methadone treatment.
  
• The Certified Methadone Advocate (CMA) – the mechanism of certification and how it will professionalize those committed to advocacy. Including advocacy on the Net and Methadone Anonymous.
  
• Methadone Stigma – a history of administrative and community prejudice directed at methadone patients, plus analyses of possible solutions.
  
• Methadone Treatment & Pregnancy – Understanding the issues, specific implications and methods of treatment for pregnant women undergoing ODT, advocating in a legal setting, advocating in a health services community, advocating for the newborn in a health treatment facility setting.
  
• Hepatitis C & HIV/AIDS – Addressing this aspect of healthcare, vital information for all opiate addicted individuals, including but not limited to treatment, legal, social and confidentiality issues.

Candidates for certification must register with NAMA prior to the conference. Registration information available at: www.methadone.org/registration.doc

On-site registration will be 8:00 AM to 9:00 AM at the NAMA table outside meeting room. NAMA cannot guarantee a place to anyone not
pre-registered.

Sponsored by the National Alliance of Methadone Advocates (NAMA). Supported by the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment and Mallinckrodt, Inc.